SUMMARY Dexamethasone palmitate was incorporated into a lipid emulsion (Intralipid, Intralipos) and was injected into rats, and its distribution in the organs and tissues and its antiinflammatory effects were compared with those of free dexamethasone disodium phosphate. The distribution patterns of [3H] dexamethasone were markedly different between the 2 preparations in 3 hours after intravenous administration. Dexamethasone palmitate given as a lipid emulsion showed a much higher concentration in the blood, spleen, and inflamed tissues (carrageenan oedema), whereas dexamethasone sodium phosphate had a high concentration in the muscles. The anti-inflammatory activity of both preparations given intravenously was evaluated by using the preformed carrageenan granuloma pouch method. The anti-inflammatory activity of lipid emulsion dexamethasone was 5 -6 times as potent as 
The incorporation of a number of drugs in liposomes has been shown to increase their effectiveness and to reduce toxicity.' Liposomes are easily taken up by and retained in phagocytes such as macrophages. By virtue of this property liposome-incorporated corticosteroids inhibit certain types of inflammation in man and animals more intensively than a corresponding dose of free corticosteroids. The problems of liposomal therapy seem to be instability of liposomes and a shortage of experience in clinical use. We incorporated dexamethasone palmitate in a lipid emulsion (Intralipid), which is stable and in widespread use for parenteral nutrition in man. In this paper we report on the tissue distribution pattern of dexamethasone incorporated in a lipid emulsion and its anti-inflammatory activity in the rats.
Materials and methods
Corticosteroids. Dexamethasone was purchased from Roussel Uclaf Co. Ltd. [6-7-3H(N) Accordingly we tried substituting a lipid emulsion for liposome as carrier of corticosteroids to obtain a beneficial distribution. The present study clearly showed that the distribution of corticosteroids into such RES-rich organs as the spleen (Fig. 2) and into inflamed tissues (Table 2) was much greater when corticosteroids were given as a lipid emulsion than an equivalent amount of corticosteroids alone. Therefore a stronger anti-inflammatory activity of corticosteroids incorporated in lipid emulsion is suggested. It was found in this study that the anti-inflammatory activity of lipid emulsion dexamethasone was 5-6 times as potent as the corresponding amount of free dexamethasone. Inhibition of neutrophil chemotaxis has been reported in patients receiving lipid emulsion alone.8 However, in the rats given lipid emulsion lacking dexamethasone in our experiment there was no significant effect on their granuloma pouches.
Our study suggests that lipid emulsion corticosteroids are useful in the treatment of several types of diseases. They may include such inflammatory diseases as rheumatoid arthritis, where phagocytic cells in joints have an important role in the pathogenesis, and such diseases as autoimmune haemolytic anaemia and idiopathic thrombocytopenic purpra, in which corticosteroids are effective at least partly by blocking the RES.
